WST · ISSUER CIK 105770
WEST PHARMACEUTICAL SERVICES INC
Between Aug 1, 2026 and Oct 29, 2026, 2 WEST PHARMACEUTICAL SERVICES INC insiders reported $0.00 of open-market purchases and $5.4M of sales on SEC Form 4.
↗2 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 1 of 2 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$5.4MInsider selling
−$5.4MNet open-market
Sep 15, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 202616:37 | Sep 15, 2026from Sep 11, 2026 | WST | Sr. VP & Chief HR Officer | S · Sell10b5-1 | $355.03 | −7,524 | 21,818 | -26% | −$2.7M | ||
| Sep 15, 202616:37 | Sep 15, 2026from Sep 11, 2026 | WST | Sr. VP & Chief HR Officer | M · Exercise10b5-1 | $89.64 | +7,524 | 24,342 | +45% | $674K | ||
| Sep 10, 202617:36 | Sep 8, 2026 | WST | Sr. VP & Chief HR Officer | S · Sell | $340.81 | −8,135 | 16,845 | -33% | −$2.8M | ||
| Sep 10, 202617:36 | Sep 8, 2026 | WST | Sr. VP & Chief HR Officer | M · Exercise | $85.37 | +8,135 | 19,345 | +73% | $694K | ||
| Aug 12, 202614:56 | Aug 11, 2026 | WST | SVP & Chief Financial Officer | M · Exercise | — | +7,149 | 9,784 | +271% | — | ||
| Aug 12, 202614:56 | Aug 11, 2026 | WST | SVP & Chief Financial Officer | F · Tax | $351.37 | −3,109 | 7,021 | -31% | $1.1M |